Ever since the massive Women's Health Initiative (WHI) found, 22 years ago, that hormone replacement therapy (HRT) increased the risk of heart attacks by 29 percent, breast cancer by 26 percent, stroke by 41 percent and doubled the risk of blood clots, drug makers have sought a replacement for its lucrative franchise.
